Skip to main content

Table 2 Association of Chronic Kidney Disease and Apo-lipoprotein B in the study subjects (N = 8322)

From: Apolipoprotein B and renal function: across-sectional study from the China health and nutrition survey

VariableModel 1cModel 2cModel 3cModel 4cModel 5c
ORa1.781.481.391.281.29
(95% CIa)(1.67, 1.89)(1.38, 1.58)(1.29, 1.49)(1.14, 1.44)(1.15, 1.45)
LRb− 7784.8− 6494.3− 6307.2− 6193.2− 6156.3
Chi-Square (DF)/2581.00 (5)374.30 (7)227.90 (6)73.83 (6)
t value17.8111.339.354.164.25
p (Apo B)/< 0.01< 0.01< 0.01< 0.01
  1. aOR Odds ratio, CI Confidence interval
  2. b LR test wasperformed between model 1~model 2, model 2~model 3, model 3~model 4, and model4~model5; All the P value of LR is < 0.001
  3. cModel 1: Estimate without covariate
  4. Model 2: Adjusted for demographic characteristics (age, gender, body mass index, region and education)
  5. Model 3: Adjusted for model 2, nutrient status (fat intakes, protein intakes and calorie intakes) and comorbidities (Hyperuricemia, diabetes, anemia and hypertension)
  6. Model 4: Adjusted for model 3 and biochemical indicators (hemoglobin, albumin, apo-lipoprotein A, urea nitrogen, triglycerides, total cholesterol, high-density lipoprotein and low-density lipoprotein)
  7. Model 5: Adjusted for model 4 and life style (smoking, alcohol drinking, water drinking, tea drinking, screen view and sleeping duration)